Advancing stroke therapy: innovative approaches with stem cell-derived extracellular vesicles

Area of Science:

• Neuroscience
• Regenerative Medicine
• Biotechnology

Background:

• Stroke, particularly acute ischemic stroke (AIS), is a major global cause of death and disability.
• Current reperfusion therapies for AIS have limitations, necessitating new treatment strategies.
• Stem cell-derived extracellular vesicles (EVs) offer potential therapeutic benefits for AIS.

Purpose of the Study:

• To review the therapeutic potential of stem cell-derived EVs in AIS.
• To explore their mechanisms of action, origin, and biogenesis.
• To discuss strategies for enhancing EV efficacy and combination therapies.

Main Methods:

• Literature review of current research on stem cell-derived EVs in AIS.
• Analysis of EV mechanisms, modifications, and combination therapies.
• Discussion of challenges and future prospects for EV-based treatments.

Main Results:

• Stem cell-derived EVs promote neuronal survival, reduce neuroinflammation, protect the blood-brain barrier, and enhance angiogenesis and neurogenesis in AIS models.
• Targeting and cargo modifications can improve EV efficacy.
• Combination therapies (e.g., with reperfusion, nanomedicine) show promise for better stroke outcomes.

Conclusions:

• Stem cell-derived EVs represent a novel therapeutic avenue for AIS, addressing limitations of current treatments.
• Challenges include EV heterogeneity and standardization of production and quality control.
• Further research is crucial for optimizing EV therapies and clinical translation, focusing on safety and targeted delivery.